Tactile Systems Technology (NASDAQ:TCMD) Lowered to “Buy” Rating by StockNews.com

StockNews.com cut shares of Tactile Systems Technology (NASDAQ:TCMD) from a strong-buy rating to a buy rating in a research report sent to investors on Monday.

Other equities analysts have also recently issued research reports about the stock. B. Riley started coverage on shares of Tactile Systems Technology in a research report on Thursday, September 26th. They set a “buy” rating and a $23.00 target price for the company. BTIG Research lowered shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. Finally, Oppenheimer lowered shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th.

Tactile Systems Technology Stock Performance

Shares of TCMD opened at $18.92 on Monday. The company has a current ratio of 4.37, a quick ratio of 3.80 and a debt-to-equity ratio of 0.12. The stock has a market cap of $454.08 million, a P/E ratio of 29.11 and a beta of 1.17. The company has a 50-day moving average of $14.76 and a two-hundred day moving average of $13.36. Tactile Systems Technology has a 12-month low of $11.12 and a 12-month high of $19.55.

Hedge Funds Weigh In On Tactile Systems Technology

A number of institutional investors have recently modified their holdings of the company. Arcadia Investment Management Corp MI purchased a new stake in Tactile Systems Technology in the third quarter valued at approximately $29,000. Gladius Capital Management LP purchased a new stake in Tactile Systems Technology in the third quarter valued at approximately $44,000. Quarry LP purchased a new stake in Tactile Systems Technology in the second quarter valued at approximately $46,000. State Board of Administration of Florida Retirement System purchased a new stake in Tactile Systems Technology in the first quarter valued at approximately $171,000. Finally, SG Americas Securities LLC purchased a new stake in Tactile Systems Technology in the third quarter valued at approximately $156,000. Institutional investors and hedge funds own 83.43% of the company’s stock.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.